Clinical Trials Browser

Phase 2 × Observation × Other hematologic neoplasm × Clear all

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03059485 2026-02-04

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute